PT1609863E - Polipéptidos segregados e transmembranares e ácidos nucleicos que os codificam - Google Patents

Polipéptidos segregados e transmembranares e ácidos nucleicos que os codificam Download PDF

Info

Publication number
PT1609863E
PT1609863E PT05014619T PT05014619T PT1609863E PT 1609863 E PT1609863 E PT 1609863E PT 05014619 T PT05014619 T PT 05014619T PT 05014619 T PT05014619 T PT 05014619T PT 1609863 E PT1609863 E PT 1609863E
Authority
PT
Portugal
Prior art keywords
polypeptides
present
secreted
same
nucleic acids
Prior art date
Application number
PT05014619T
Other languages
English (en)
Inventor
Colin K Watanabe
Timothy A Stewart
Audrey Goddard
Luc Desnoyers
Dan L Eaton
Paul J Godowski
Zemin Zhang
Austin L Gurney
James Pan
William I Wood
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of PT1609863E publication Critical patent/PT1609863E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
PT05014619T 1999-03-23 2000-03-01 Polipéptidos segregados e transmembranares e ácidos nucleicos que os codificam PT1609863E (pt)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US12577499P 1999-03-23 1999-03-23
US12577899P 1999-03-23 1999-03-23
US12582699P 1999-03-24 1999-03-24
US12703599P 1999-03-31 1999-03-31
US12770699P 1999-04-05 1999-04-05
US13035999P 1999-04-21 1999-04-21
US13127099P 1999-04-27 1999-04-27
US13127299P 1999-04-27 1999-04-27
US13129199P 1999-04-27 1999-04-27
US13237199P 1999-05-04 1999-05-04
US13237999P 1999-05-04 1999-05-04
US13238399P 1999-05-04 1999-05-04
US13575099P 1999-05-25 1999-05-25
US13816699P 1999-06-08 1999-06-08
US14479199P 1999-07-20 1999-07-20
US14697099P 1999-08-03 1999-08-03
US17026299P 1999-12-09 1999-12-09

Publications (1)

Publication Number Publication Date
PT1609863E true PT1609863E (pt) 2009-01-02

Family

ID=27586019

Family Applications (3)

Application Number Title Priority Date Filing Date
PT05014619T PT1609863E (pt) 1999-03-23 2000-03-01 Polipéptidos segregados e transmembranares e ácidos nucleicos que os codificam
PT05011885T PT1616878E (pt) 1999-03-23 2000-03-01 Polipéptidos segregados e transmembranares e ácidos nucleicos que os codificam
PT00917717T PT1169442E (pt) 1999-03-23 2000-03-01 Polipeptidos segregados e transmembranares e acidos nucleicos que os codificam

Family Applications After (2)

Application Number Title Priority Date Filing Date
PT05011885T PT1616878E (pt) 1999-03-23 2000-03-01 Polipéptidos segregados e transmembranares e ácidos nucleicos que os codificam
PT00917717T PT1169442E (pt) 1999-03-23 2000-03-01 Polipeptidos segregados e transmembranares e acidos nucleicos que os codificam

Country Status (11)

Country Link
EP (4) EP1609863B1 (pt)
JP (8) JP4174183B2 (pt)
KR (1) KR100504305B1 (pt)
AT (4) ATE417063T1 (pt)
AU (1) AU764092B2 (pt)
CA (1) CA2361221A1 (pt)
DK (3) DK1609863T3 (pt)
ES (3) ES2269125T3 (pt)
NZ (3) NZ527292A (pt)
PT (3) PT1609863E (pt)
WO (1) WO2000056889A2 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525174B1 (en) 1997-06-06 2003-02-25 Human Genome Sciences, Inc. Precerebellin-like protein
US7193045B2 (en) 1998-05-15 2007-03-20 Genetech, Inc. Polypeptides that induce cell proliferation
JP5456222B2 (ja) 1998-12-23 2014-03-26 ジェネンテック， インコーポレイテッド Ｉｌ−１関連ポリペプチド
EP1200590B1 (en) 1999-08-12 2009-01-07 Agensys, Inc. C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
US7842458B2 (en) * 1999-08-12 2010-11-30 Agensys, Inc. Nucleic acids and corresponding proteins entitled 58P1D12 useful in treatment and detection of cancer
CA2400472A1 (en) * 2000-02-08 2001-08-16 Amgen, Inc. Il-17 like molecules and uses thereof
US7067297B2 (en) 2000-02-15 2006-06-27 Chugai Seiyaku Kabushiki Kaisha Mannosyltransferase polypeptides and polynucleotides encoding them and methods for making and using them
AU2001233957A1 (en) * 2000-02-24 2001-09-03 Oxford Glycosciences (Uk) Limited Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (bad) and unipolar depression
AU2001244615A1 (en) * 2000-03-29 2001-10-08 Kyowa Hakko Kogyo Co. Ltd. Proliferative glomerular nephritis-associated gene
EP1339845A2 (en) 2000-12-07 2003-09-03 ZymoGenetics, Inc. Adipocyte complemented related protein zacrp3x2
JP4344519B2 (ja) * 2000-12-28 2009-10-14 旭化成ファーマ株式会社 ＮＦ−κＢ活性化遺伝子
AU2002229091A1 (en) * 2001-06-20 2003-01-08 Genentech, Inc. Secreted polypeptide and their use in the treatment of bone disorders
EP1513875A2 (en) * 2002-05-10 2005-03-16 Serono Genetics Institute S.A. Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders
AU2003241979A1 (en) * 2002-05-31 2003-12-19 Hidetoshi Inoko Inflammatory skin disease-related slurp-2 gene and utilization thereof
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
EP1790664A1 (en) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
ES2625259T3 (es) 2006-08-29 2017-07-19 Oxford Biotherapeutics Ltd Identificación de proteína asociada con carcinoma hepatocelular, glioblastoma y cáncer de pulmón
BRPI1009232B1 (pt) 2009-03-05 2022-05-03 E.R. Squibb & Sons, Llc. Anticorpo monoclonal isolado ou uma porção de ligação de antígeno do mesmo, ou um fragmento de anticorpo, composição que os compreende, molécula de ácido nucleico, hibridoma e métodos para a preparação de um anticorpo anti-cadm1
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
KR101695792B1 (ko) * 2014-09-04 2017-01-12 디오셀 주식회사 신규 세포막 투과 펩티드 및 생리활성 물질 전달체로서의 그의 용도

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US5206161A (en) 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
US6001970A (en) * 1994-11-07 1999-12-14 Merck & Co., Inc Modified human neuropeptide Y1 Receptors
WO1997025427A1 (en) * 1996-01-12 1997-07-17 Genetics Institute, Inc. Beta-chemokine, h1305 (mcp-2)
WO1999006551A2 (en) * 1997-08-01 1999-02-11 Genset 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES
CA2296287A1 (en) * 1997-08-01 1999-02-11 Genset 5' ests for secreted proteins expressed in prostate
CA2311572A1 (en) * 1997-12-17 1999-06-24 Genset S.A. Extended cdnas for secreted proteins
EP1068312A2 (en) * 1998-04-09 2001-01-17 Genset 5' ests and encoded human proteins
NZ507728A (en) * 1998-04-29 2002-06-28 Genesis Res & Dev Corp Ltd Information from a cDNA library created from keratinocytes, dermal papilla, neonatal foreskin fibroblast or embryonic skin cells is used to treating cancer, angiogenesis, skin inflammation, inflammatory diseases or stimulating keratinocyte growth
EP1140970A4 (en) * 1998-12-17 2003-10-22 Human Genome Sciences Inc 47 HUMAN SECRETED PROTEINS
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
CA2383592A1 (en) * 1999-03-31 2000-10-05 Curagen Corporation 2384891 acids including open reading frames encoding polypeptides; orfx
AU779667B2 (en) * 1999-06-23 2005-02-03 Curagen Corporation Polynucleotides and polypeptides encoded thereby
EP1074617A3 (en) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins
EP1200590B1 (en) * 1999-08-12 2009-01-07 Agensys, Inc. C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
WO2001012660A2 (en) * 1999-08-17 2001-02-22 Sagami Chemical Research Center HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
US6635742B1 (en) * 2000-01-25 2003-10-21 Nuvelo, Inc. Antibodies specific for semaphorin-like polypeptides

Also Published As

Publication number Publication date
EP1688430A3 (en) 2006-11-02
DK1616878T3 (da) 2009-03-30
JP2010075189A (ja) 2010-04-08
PT1169442E (pt) 2006-10-31
JP2006136325A (ja) 2006-06-01
NZ527292A (en) 2005-03-24
JP2003527074A (ja) 2003-09-16
DK1609863T3 (da) 2008-12-15
CA2361221A1 (en) 2000-09-28
JP4392759B2 (ja) 2010-01-06
EP1688430B1 (en) 2009-11-18
JP4398937B2 (ja) 2010-01-13
WO2000056889A2 (en) 2000-09-28
EP1616878B1 (en) 2008-12-10
NZ527293A (en) 2005-01-28
ES2319202T3 (es) 2009-05-05
EP1609863A2 (en) 2005-12-28
EP1688430A2 (en) 2006-08-09
ES2314521T3 (es) 2009-03-16
ATE409228T1 (de) 2008-10-15
ATE449108T1 (de) 2009-12-15
WO2000056889A3 (en) 2001-04-26
KR20010112927A (ko) 2001-12-22
EP1609863A3 (en) 2006-04-12
ES2269125T3 (es) 2007-04-01
JP4174183B2 (ja) 2008-10-29
DK1169442T3 (da) 2006-10-16
JP2006101881A (ja) 2006-04-20
JP2006158392A (ja) 2006-06-22
JP2006115847A (ja) 2006-05-11
EP1169442A2 (en) 2002-01-09
JP4392760B2 (ja) 2010-01-06
AU764092B2 (en) 2003-08-07
JP4402034B2 (ja) 2010-01-20
JP2006101880A (ja) 2006-04-20
EP1616878A1 (en) 2006-01-18
KR100504305B1 (ko) 2005-07-28
EP1169442B1 (en) 2006-06-07
NZ536320A (en) 2006-04-28
EP1609863B1 (en) 2008-09-24
JP2006115848A (ja) 2006-05-11
ATE329023T1 (de) 2006-06-15
ATE417063T1 (de) 2008-12-15
PT1616878E (pt) 2009-03-18
AU3864800A (en) 2000-10-09

Similar Documents

Publication Publication Date Title
IL134968A0 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001016318A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001040466A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2000053756A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2000077037A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU3774300A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001068848A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2002008288A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
MXPA01002592A (es) Polipeptidos de transmembrana y secretados y acidos nucleicos que codifican los mismos.
WO2002024888A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
KR100468977B1 (ko) 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산
PT1609863E (pt) Polipéptidos segregados e transmembranares e ácidos nucleicos que os codificam
KR100515858B1 (en) PRO617 Polypeptides
KR100514267B1 (en) Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same
KR100514268B1 (en) Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same
EP1300417A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
ZA200103757B (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same.
DE69926415D1 (de) Sekretiertes Polypeptide und dafür kodierende Nukleinsäuren
KR100515855B1 (en) PRO351 Polypeptides
KR100515856B1 (en) PRO618 Polypeptides
EP1464654A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
DK1621619T3 (da) Secernerede polypeptider og transmembran-polypeptider og nukleinsyrer, der koder for disse
EP1217006A3 (en) Polypeptides and nucleic acids encoding the same
PT1241184E (pt) Proteína semelhante a sinaptogirina e ácidos nucleicos que a codificam